HomeBUSINESS
BUSINESS

Pfizer Sues Meiji Seika Pharma, Claiming Infringement of Zyvox Patent
(Dec.5.2017)

Pfizer Japan filed a lawsuit with the Tokyo District Court on November 29 against Meiji Seika Pharma, which markets a generic version of Pfizer’s antibiotic Zyvox (linezolid), alleging that Meiji Seika Pharma has infringed its exclusive license for its patent concerning methicillin-resistant Staphylococcus aureus (MRSA) infections. Pfizer is demanding a partial ban on sales and approximately 82 million yen in compensation for damages ...
(LOG IN FOR FULL STORY)

News Calendar